secwatch.observer — SEC 8-K summary
======================================

Issuer:     MYRIAD GENETICS INC (MYGN)
CIK:        0000899923
Form:       8-K
Filed at:   2026-06-04T20:08:53+00:00
Accession:  0000899923-26-000059
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Myriad Genetics shareholders approve equity plan amendments, elect directors at 2026 annual meeting
--------------------------------------------------------------------------------

- Approved amendment to ESPP increasing authorized shares by 4,000,000.
- Approved 2026 Equity Incentive Plan with total reserve of 8,463,567 shares.
- Elected Class III directors Paul Bisaro, Rashmi Kumar, Lee Newcomer with over 60M votes each.
- Ratified Ernst & Young as independent auditor for 2026 with 76.3M for, 1.4M against.
- Advisory vote approved executive compensation with 59.4M for, 3.1M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/899923/000089992326000059/0000899923-26-000059-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/899923/000089992326000059/mygn-20260604.htm
  HTML page:      https://secwatch.observer/filing/0000899923-26-000059

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer